New virus strain's transmissibility to cause more deaths: Study

The variant is 56% more transmissible than other strains, according to the study

coronavirus, London
Medical workers wearing equipment to protect themselves from coronavirus bring a patient to St Thomas' Hospital in Westminster in London. Photo: PTI
Corinne Gretler | Bloomberg
2 min read Last Updated : Dec 24 2020 | 3:57 PM IST
The mutated coronavirus strain that’s been spreading in the U.K. appears to be more contagious and will likely lead to higher levels of hospitalizations and deaths next year, a new study showed.
 
The variant is 56% more transmissible than other strains, according to the study by the Centre for Mathematical Modelling of Infectious Diseases at the London School of Hygiene and Tropical Medicine. There’s no clear evidence that it results in more or less severe disease.

The U.K. government had previously said the mutated variant appears to be as much as 70% more transmissible than other circulating strains. Additionally, it has almost two dozen mutations that may affect proteins made by the coronavirus, Patrick Vallance, the U.K.’s chief scientific adviser, said on Dec. 19.

That has raised concern that tests, treatments and vaccines that just started rolling out might be less effective, though Europe’s health regulator said the variant probably isn’t different enough from earlier ones to elude Pfizer Inc. and BioNTech SE’s shot. Countries including Australia, Denmark and Singapore have also discovered the strain.

Measures like England’s national lockdown in November are unlikely to reduce the reproduction number -- the new infections estimated to stem from a single case -- to less than 1 unless schools and universities are also closed, the report said. It also said vaccine rollouts may need to be accelerated to contain its spread, to a rate of 2 million people a week from the current pace of 200,000.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusUKCoronavirus TestsCoronavirus Vaccine

Next Story